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a b s t r a c t
Polyaniline is a promising conducting polymer with still increasing application potential in biomedicine.
Its surfacemodiﬁcation can be an efﬁcientway how to introduce desired functional groups and to control
its properties while keeping the bulk characteristics of the material unchanged. The purpose of the study
was to synthetize thin ﬁlms of pristine conducting polyaniline hydrochloride, non-conducting polyani-
line base and polyaniline modiﬁed with poly(2-acrylamido-2-methyl-1-propanesulfonic acid) (PAMPSA)
and investigate chosen parameters of their hemocompatibility. The modiﬁcation was performed either
by introduction of PAMPSA during the synthesis or by reprotonation of polyaniline base. The polyani-
line hydrochloride and polyaniline base had no impact on blood coagulation and platelet adhesion. By
contrast, the polyaniline reprotonatedwith PAMPSA completely hindered coagulation thanks to its inter-
action with coagulation factors Xa, Va and IIa. The signiﬁcantly lower platelets adhesion was also found
on this surface. Moreover, this ﬁlm maintains its conductivity at pH of 6, which is an improvement inlood coagulation
latelet adhesion
comparisonwith standardpolyanilinehydrochloride losingmost of its conductivity at pHof 4. Polyaniline
ﬁlmwithPAMPSA introducedduring synthesis had an impact onplatelet adhesionbutnot on coagulation.
The combined conductivity, anticoagulation activity, low platelet adhesion and improved conductivity
at pH closer to physiological, open up new possibilities for application of polyaniline reprotonated by
PAMPSA in blood-contacting devices, such as catheters or blood vessel grafts.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license. Introduction
Despite remarkable progress in understanding the blood coag-
lation system, as well as in the development of blood-compatible
iomaterials and blood-contacting devices, the problem of foreign-
urface-induced thrombosis still remains unsolved [1]. In fact,
he contact of any material with blood induces multiple defen-
ive mechanisms, such as the activation of coagulation cascade,
latelet adhesion, the triggering of complementary systems, and
thers [2]. The most common compound with known anticoagu-
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ata University in Zlin, T.G.M. Sq. 5555, 760 01 Zlin, Czech Republic.
el.: +420 734 792 298; fax: +420 57 603 1444.
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ttp://dx.doi.org/10.1016/j.colsurfb.2015.06.008
927-7765/© 2015 The Authors. Published by Elsevier B.V. This is an open access article u(http://creativecommons.org/licenses/by/4.0/).
lant activity is heparin, and its efﬁcacy is mainly ascribed to the
simultaneous presence of sulfate, sulfamic, and carboxylic groups
and their arrangement along the polysaccharide backbone of this
polymer (Fig. 1a). It has already been reported that synthetic poly-
mersandcopolymerswithheparin-likeactivitymightbeapplicable
to medical devices or surfaces coming into contact with blood.
Polyaniline (PANI), as a conducting polymer, has immense
potential with regard to practical applications in the biomedical
ﬁeld. In particular, cardiomyocyte synchronization [3], myoblast
differentiation [4], neuronal lineage differentiation, and cardiac
tissue engineering [5] have been highlighted with respect to
the use of conducting polymers. Commonly, the standard PANI,
emeraldine salt is prepared via oxidative polymerization of aniline
hydrochloride with ammonium peroxydisulfate [6]. Considering
the biological properties of PANI, the number of papers is surpris-
ingly limited. Humpolicek et al. [7] studied pristine PANI powders
nder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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2.1. Deposition of polyaniline ﬁlms
The surfaces of blood collection tubes (Vacuette, Austria) were
coated with conducting ﬁlms of PANI hydrochloride. AnilineFig. 1. Formulae of (a) heparin and (b) poly(
or their cytotoxicity, skin irritation and sensitization. Also cell
roliferation on PANI ﬁlms [8] and implantability in tissues was
nvestigated by Kamalesh et al. [9] and Mattioli-Belmonte et al.
10]. To the best of authors’ knowledge, no information about PANI
emocompatibility has previously been published.
Considerable advantage of PANI consists also in its ability to eas-
ly form thin ﬁlms on substrates immersed in the reaction mixture
sed for PANI preparation [11]. The ﬁlms can be further modiﬁed
y using various dopant acids with the aim to change their surface
roperties [12]. This opens new possibilities for targeted surface
odiﬁcation of PANI by acids, or generally substances showing
esired properties. Polyacids are good candidates for protonation
f PANI, and some of them alone have been observed to exhibit
otable anticoagulant effects. Methacrylic copolymers contain-
ng, similarly to heparin, the above-mentioned functional groups,
an be listed as examples [13]. Poly(2-acrylamido-2-methyl-1-
ropanesulfonic acid) (PAMPSA; Fig. 1b) was shown to act against
lood clotting in a similarway to heparin, either alone [14] or incor-
orated in copolymers [15]. Setoyama et al. [16] also reported that
AMPSA is capable of inhibiting the activation of serum comple-
ent activity, which is another important factor with respect to
he applicability of materials in biomedical engineering.
In the present study, PANI has a dual role. The ﬁrst is repre-
ented by easy modiﬁcation of surfaces by deposition of thin PANI
lms of sub-micrometre thickness. This is done in situ on sub-
trates immersed in the reaction mixture used for the oxidation of
niline [11]. The second role then consists in the subsequent immo-
ilization of PAMPSA onto PANI ﬁlms by the formation of a salt
Fig. 2). The feasibility of a polyanion–polycation complex forma-
ionbetweenPANIandPAMPSAhasbeendemonstrated [17,18] and
he resulting material was used in the electrodes of energy-storage
evices [19,20]. PANI ﬁlms with PAMPSA have also been tested for
heir biocompatibility [21], and normal cell adhesion, proliferation,
nd low cytotoxicity was observed. Polymer combining hemocom-
atibility and conductivity can bewith advantage used for example
n biosensors. These types of sensing materials can be safely placed
n vivo while monitoring the desired parameters via conductiv-
ty. Moreover, inherently conducting PANI can easily be combined
ith other biocompatible materials and applied for example for
rtiﬁcial blood vessels where electrical performance can be used
o monitor a range of medically important parameters, such as
riacylglycerol/cholesterol concentration in blood or velocity of
lood ﬂow. A growing interest has been also in electrochemical
ensors capable of in vivo monitoring of metabolites, for exam-
le glucose, hormones, neurotransmitters, antibodies and antigens
22,23].lamido-2-methyl-1-propanesulfonic acid).
The present paper is focused on the changes in blood coagu-
lation and platelet adhesion induced by the surfaces of different
PANI ﬁlms, namely PANI hydrochloride, PANI base and PANI
salts with PAMPSA. The ﬁlms with PAMPSA were prepared
using two procedures. In the ﬁrst, reprotonation of PANI base
using PAMPSA solution was performed giving rise to ﬁlms with
acid deposited onto the PANI surface. In the second procedure,
a standard oxidative polymerization of aniline was conducted,
with PAMPSA added directly into the reaction mixture of ani-
line hydrochloride and ammonium peroxydisulfate. While the
PANI ﬁlm reprotonated with PAMPSA contains exclusively poly-
meric counter-ions, the second PANI is protonated in part with
sulfuric acid produced in the course of aniline oxidation from
peroxydisulfate.
2. Materials and methodsFig. 2. Polyaniline salt with poly(2-acrylamido-2-methyl-1-propanesulfonic acid).
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ydrochloride (2.59g; Sigma-Aldrich) was dissolved in water to
ield 50mLof solution; ammoniumperoxydisulfate (5.71g; Sigma-
ldrich)was similarly dissolved to 50mLof solution. Subsequently,
oth solutions were mixed at room temperature and immediately
oured into tubes [11]. The concentrations of reactants were thus
.2M aniline hydrochloride and 0.25M ammonium peroxydisul-
ate [6]. After 1h, the tubes were emptied and the ﬁlms of green
onducting PANI hydrochloride deposited on the walls were rinsed
ith 0.2M hydrochloric acid, followed by methanol, and left to dry
n air for 5 days.
Someﬁlmswere deprotonated by immersion in 1Mammonium
ydroxide for 12h and thus converted to blue, non-conducting
lms of PANI base.
In order to prepare ﬁrst type of PANI ﬁlm with poly(2-
crylamido-2-methyl-1-propanesulfonic acid) (PANI–PAMPSA),
he reprotonation of PANI base with a 7.5% (v/v) aqueous solution
f PAMPSA (molecular weight M=2×106 gmol−1, Sigma-Aldrich)
as performed by exposing the ﬁlm to the PAMPSA solution. The
eutralization reaction was left to proceed for 24h; then the resid-
al PAMPSA solution was poured out, the ﬁlm was rinsed with
ethanol and left to dry in air.
The second type of ﬁlm combining PANI and PAMPSA was pre-
ared with PAMPSA present in the reaction mixture of aniline
ydrochloride and ammonium peroxydisulfate. For this purpose,
odiﬁed procedures published by Stejskal et al. [24], Yoo et al.
25], and Bayer et al. [21] were employed. First, an aqueous
olution of PAMPSA was prepared with a target concentration
orresponding to 0.028mol (5.8 g) of its constitutional unit, (2-
crylamido-2-methyl-1-propanesulfonic acid). In practice, 38.5mL
f 15% PAMPSA solution was diluted by water to 375mL. Aniline
ydrochloride (0.028mol, 3.6 g) was then added to the PAMPSA
olution and stirred at room temperature for 1h. The mole ratio of
niline hydrochloride to PAMPSA units was adjusted to 1:1 (PANI-
:1). Then the oxidant, ammonium peroxydisulfate (0.025mol,
.8 g), at a 1:0.9 aniline hydrochloride to oxidant mole ratio,
as dissolved separately in 25mL water and added to this solu-
ion. The polymerization was completed within 60min. The ﬁlms
ere rinsed with water to remove the adhering precipitate and
eft to dry in air. In the contrast to PANI–PAMPSA, the PANI-
:1 ﬁlm contains also sulfate or hydrogen sulfate counter-ions
roduced by the decomposition of peroxydisulfate in addition to
AMPSA. For that reason, the molecular structure of PANI-1:1
ay be structurally closer to PANI hydrochloride ﬁlms than to
ANI–PAMPSA.
.2. Spectroscopic characterization
The UV–Vis spectra of ﬁlms were recorded in the presence of
uffer solutions with pH ranging from 2 to 12 using the UV/VIS
pectrometer (Lambda 25, Perkin Elmer, UK). The inner surfaces
f standard polystyrene cuvettes were coated by PANI–PAMPSA
lms according to procedure described above. The buffer solu-
ions consisted of 0.0225M solutions of citric acid (monohydrate)
≥99.5%), Tris (p.a.≥99.8%), KCl (p.a.≥99.5%), obtained from Fluka,
H2PO4 and Na2B4O7·10H2O (Merck), and the pH was adjusted
n the individual buffer solutions by adding either HCl or NaOH
olutions. In the UV–Vis measurements, a syringe was used to
anually ﬁll the sample cuvettes with buffer solution and to
emove the previous solution. UV–Vis spectra were recorded
ithin the wavelength range 360–1100nm after 1h at each
H.Fourier-transform infrared (FTIR) spectra of the ﬁlms deposited
n silicon windows were recorded with a Thermo Nicolet
EXUS 870 FTIR Spectrometer with a DTGS TEC detector in the
00–4000 cm−1 wavenumber region.B: Biointerfaces 133 (2015) 278–285
2.3. Contact angle measurements
Contact angle measurements were conducted with the aid of
the “SEE system” (surface energy evaluation system) (Advex Instru-
ments, CzechRepublic)withdeionizedwater as a testing liquid. The
droplet volume was set to 2L in all experiments.
2.4. Anticoagulation test
In all tests, venous blood was collected from healthy donors by
venipuncture using the vacuum blood collection system into the
5mL collecting tubes (VACUETTE, Greiner Bio-One) after obtain-
ing informed consent. All tests were conducted in accordance
with the Helsinki Declaration. Plasma was prepared by centrifu-
gation (15min, 3000× g). The following coagulation parameters in
human blood plasma treated with citric acid (0.109mol/L) have
been studied: (1) thrombin clotting time (TCT), (2) activated par-
tial thromboplastin time (aPTT), and (3) prothrombin time (PT).
The tests were performed using a SYSMEX CA-1500 (Siemens,
Germany). Each of the samples was assessed three times. To deter-
mine the interactionof PANIﬁlmson the surfacewithbloodplasma,
the coagulation factorsXa (Stuart-Prower factor), Va (proaccelerin),
IIa (prothrombin), factor I (ﬁbrinogen), antithrombin III (AT) andD-
dimerwere selected and the followingmethodswere employed for
their determination. TheClauss assaywas used to detect the impact
on factor I using a SYSMEX CA-1500 (Siemens, Germany). The same
equipment with INNOVANCE® Antithrombin and INNOVANCE D-
Dimer reagents was used to determine the AT and D-dimer. The
activities of factors Xa, Va and IIa in the plasma have been deter-
mined by a modiﬁed prothrombin time test using an ACL ELITE
Pro (IL-Instruments, Italy). Tested plasma was diluted and added
to commercial plasma which was deﬁcient always in one of the
individual factors (HemosILTM, Instrumentation Laboratory, USA).
The clotting time of the deﬁcient plasma is proportional to the con-
centration (% activity) of a factor in the tested plasma, interpolated
from a calibration curve.
2.5. Platelet adhesion
Additional information about the interaction of ﬁlms with
human blood was obtained by the modiﬁed TOX 6 assay (Sigma-
Aldrich, USA). For this type of experiment, the PANI ﬁlms were
deposited on discs of 10mm diameter. The discs were subse-
quently incubated in the presence of 1mL of human blood. Sample
incubation was performed in a 24-well microtiter plate at 37 ◦C
under shaking at 200 rpm for 15min. After incubation, the sam-
ples were rinsed with phosphate buffered saline in order to
remove all unattached blood constituents and ﬁxed with 1mL 50%
trichloroacetic acid (Sigma-Aldrich) at 4 ◦C. After 1h the platelets
adhered on the surface were stained with the Sulforhodamine B.
The incorporated dye was liberated from the platelets using Tris
base solution.Difference in thenumberof platelets ondifferent sur-
faces results in the amount of dye incorporated by the platelets. The
incubation of all samples without blood was performed to reveal
if used dye did not interact with tested surfaces. The intensity of
released colour by the means of absorbance was measured with a
Lambda 1050 UV/VIS/NIR spectrophotometer (Perkin Elmer, USA)
at a wavelength of 565nm. The assay was performed on three discs
in triplicates.
3. Results and discussion3.1. Blood plasma coagulation
Standard ﬁlms of PANI hydrochloride, PANI base and PANI-1:1
did not have any signiﬁcant impact on the coagulation parameters
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Table 1
Impact of PANI surfaces on selected coagulation parameters expressed as times (s) to the coagulation start.
Referencea PANI base PANI hydrochloride PANI–PAMPSA PANI-1:1
PT 12.1 ± 0.1 11.9 ± 0.2 12.2 ± 0.1 NCb 12.0 ± 0.1
aPPT 26.4 ± 0.1 25.6 ± 1.1 26.4 ± 0.0 NCb 29.9 ± 0.2
TCT 18.6 ± 0.1 16.7 ± 0.1 17.56 ± 0.2 NCb 18.8 ± 0.1
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Ia The surface of blood collection tube.
b No coagulation. Normal ranges for a healthy person are: PT 11.0–13.5, aPTT 25–
Table 1). The coagulation on the PANI–PAMPSA surface, however,
as prevented. The fact that neither standard PANI hydrochloride
or PANI base induce any changes in blood clotting suggests that
he anticoagulant activity of PANI–PAMPSA is a surface effect of the
sed polymeric acid and is not inherently caused by PANI as such.
he role of PANI thus consists in the immobilization of PAMPSA.
his conclusion can be supported by the fact that PANI-1:1, in
hich the PAMPSA is incorporated directly under polymerization
nto the PANI ﬁlm and not attached on its surface, does not show
he above-described anticoagulation effect. In this case, however,
lso the fraction of PAMPSA on the surface may be lower due to the
resence of sulfate counter-ions that competewith PAMPSA for the
nteraction with PANI.
In principle, three important variables inﬂuencing coagulation
f blood in the contact with foreign matter can be identiﬁed: (1)
he acidity (pH), (2) the surface charge, and (3) the interaction with
oagulation factors. As acidity is one of the above mentioned fac-
ors, the pH was measured on freshly taken blood and after blood
ddition to Vacuette tubes coated with the PANI ﬁlms. The pH of
lood was not notably inﬂuenced by any of the tested samples
nd remained within the range of values for which no effect on
lood clotting is expected (PANI hydrochloride: pH=7.02±0.01;
ANI base: pH=7.06±0.02; PANI–PAMPSA: pH=6.95±0.01). This
s understandable because the speciﬁc mass of thin PANI ﬁlms
oated on the tubes is low, of the order of 10g cm−2. Such small
uantities cannot signiﬁcantly affect the bulk acidity of the blood
n the tube. There are several studies about the impact of pH on the
lood coagulation [26], but it is generally accepted that a reduction
n thrombus formation starts at a pH below 6.8 and thus coagula-
ion is reduced [27]. Moreover, the pH values of all tested samples
ere almost equal and impact on coagulation was observed only in
ase of PANI–PAMPSA. Basedon thiswe can conclude, that reported
ffect of PANI–PAMPSA on blood plasma coagulation is not related
o change of pH value.
As to the second factor, blood coagulation on foreign materials
s activated by negative charge present on the hydrophilic surfaces
28,29]. Considering the surfaceproperties of all the tested samples,
t can be concluded that their behaviourwith respect to coagulation
s not inﬂuenced by surface charge, because negative charges on
AMPSA are balanced by the positively charged PANI backbone.
The fact that thePANI–PAMPSAﬁlmis conducting, and thusanti-
tatic, may also play some role. The conductivity alone, however,
annot be the reason for anticoagulation effect. Typical conduc-
ivities of PANI hydrochloride and PANI base are of the orders
00 and 10−11 S cm−1, respectively [6]. Irrespective of these sig-
able 2
mpact of PANI surfaces on selected coagulation factors.
Factor Referencea PANI base
Xa (%) 100 100
Va (%) 100 89.8
IIa (%) 100 92.7
I (g/L) 3.6b 3.7
AT (%) 101.4b 107.2
D-dimer (ng/mL FEU) 430b 470
a Uncoated surfaces of blood collection tube. The factors Xa, Va and IIa are expressed a
b Normal range for a healthy person are I = 2–4g/L; AT=80–120% and D-dimer =0–500T>20. The values are expressed as mean value± standard deviation, n=3.
niﬁcantly different values, the coagulation properties of both ﬁlms
are comparable. A conductivity of ≈10−2 S cm−1 was reported for
PANI–PAMPSA [17], which is a valuewithin the above interval. Also
the conductivity of PANI-1:1 with anticoagulation activity absent
does not deviate from the values typically reported for conducting
PANI and is of 1.7 S cm−1 [21].
Although it is known that both extrinsic (tissue factor) and
intrinsic (contact activation) coagulation pathways are intercon-
nected in vivo [30], the plasma-coagulation cascade is usually
divided into the two pathways for the convenience of discussion
and coagulopathy testing. It is beyond the scope of this article
to provide a comprehensive explanation of coagulation cascade
and platelet adhesion in its complexity; this can be found, for
example, in the paper by Vogler and Siedlecki [31]. Generally, PT
detects the defects or deﬁcits in extrinsic and common coagula-
tion pathways, aPTT similarly in intrinsic and common coagulation
pathways, and TCT is used for discriminating between problems in
thrombin generation (normal TCT) and the inhibition of thrombin
activity (abnormal TCT). Considering the fact that PANI–PAMPSA
inﬂuences all studied coagulation variables (Table 2), it can be con-
cluded that it affects the common pathway as a consequence of
interference with coagulation factors. Thus, the effect of ﬁlms on
the main factors of the common pathway, factor Xa, factor Va,
factor IIa, and factor I, was studied in more detail (Table 2). The
results clearly show that, in the contrast to all other tested ﬁlms,
PANI–PAMPSA interacts with factor Xa, factor Va and factor IIa. To
verify that the surfaces do not induce ﬁbrin production, its amount
was measured. The results conﬁrm that none of tested surfaces
increase the concentration of ﬁbrin (Table 2). Such effect might be
regarded as parallel to that of heparin sulfate, which binds to the
enzyme inhibitor antithrombin III (AT), thus causing its activation.
The activated AT then inactivates thrombin and other proteases
involved in blood clotting, most notably factor Xa formation found
in the common pathway. PANI–PAMPSA, therefore, might follow
a similar pathway, as it further inﬂuences factors in a common
way, with the exception of factor I. To test this theory, the activ-
ity of AT after contact with tested surfaces was performed. The
results clearly show (Table 2), that the activity of AT is physiological
after contact with all tested surfaces. The above given conclusion
indicates that althoughPAMPSAacts against bloodclotting in a sim-
ilar way to heparin, which conﬁrms the results of previous studies
[14,15], the mechanism must be different. The similarity relies on
the fact that heparin and PAMPSA exhibit some common features,
whichprobablyplaya role in their anticoagulationactivity. The fact,
that both substances are polymers, although the molecular weight
PANI hydrochloride PANI–PAMPSA PANI-1:1
98.4 25.8 94.5
70.5 0.7 86.2
86.7 0.4 83.6
3.5 2.3 3.3
110.0 101.6 104.5
450 480 460
s percentage of values determined for reference.
ng/mL FEU.
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Table 3
Platelets adhesion on PANI surfaces determined as absorbance at 565nm.
Referencea PANI base PANI hydrochloride PANI–PAMPSA PANI-1:1
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of the emeraldine salt [37,38]. This conﬁrms the protonation of the
PANI base with PAMPSA.
Absorption bands of the secondary amine –NH– and protonated
imine –NH+ are detected in the region 3400–2800 cm−1 (Fig. 4b).Platelet adhesion 2.5±0.2 2.0±0.3
a Polystyrene was used as a reference. The values are expressed as mean value±
f heparin is much lower compared to PAMPSA, and the polysac-
haride backbone of heparin is rigid in contrast to the ﬂexible chain
bserved in PAMPSA [18], must also be taken into account. More-
ver, both polymers are polyanions and both contain nitrogen- and
ulfur-containing ionizable groups. This is illustrated by the cova-
ent bond –NH–SO3− H+ in heparin (Fig. 1a) and the ionic bond
NH+ SO3− in PANI–PAMPSA (Fig. 2). On the other hand, the hep-
rin effect is complex and depends not only on mentioned factors
ut also on certain pentasaccharide sequence in the polymer. The
bove results again indicate that the role of PANI is limited to the
mmobilization of PAMPSA at its surface.
Formation of thrombus can be also initiated by protein adsorp-
ion on polymer surfaces, which can be minimized when surface
nergy is on the minimum [32]. This situation occurs on highly
ydrophilic surfaces. On the other hand, surfaces of higher
ydrophobicity are able tomore absorb the protein fromplasma, as
ell as to induce more conformation changes of the adsorbed pro-
eins [33,34]. More comments on this topic is provided in Section
.5.
.2. Platelet adhesion on polyaniline surfaces
Using sulforhodamine B colorimetric assay, the total mass of
latelets adhered to the surfaceswas determined, after the staining
f their intracellular proteins. The platelet adhesion signiﬁcantly
ecreased on both PANI ﬁlms modiﬁed with PAMPSA irrespec-
ive of whether the PAMPSA was deposited on PANI ﬁlm or
dded to the polymerization mixture. Of all the tested samples
ANI–PAMPSA exhibited the lowest platelet adhesion compared to
ANI hydrochloride, and PANI base (Table 3). The behaviour of sam-
les with PAMSA anchored to the surface or incorporated directly
nto the polymer is hence similar with respect to platelet adhe-
ion, but dissimilar with respect to the behaviour during the blood
lasma coagulation.
Surface properties can be considered as an important fac-
or in PANI/platelet interactions and therefore the water contact
ngle, as a measure of surface hydrophilicity/hydrophobicity was
etermined. The PANI hydrochloride and PANI–PAMPSA surfaces
Table 4) were the most hydrophilic of all surfaces tested and
howed similar behaviour in contact with water. The lowest
alue (34.24±1.46◦) was, however observed for ﬁlm composed
f PANI–PAMPSA. Signiﬁcant change was then observed for PANI
ase and PANI 1:1, both showing increase in contact angle
o 66.33±2.45◦ and 69.95±3.42◦, respectively. It is generally
ccepted that hydrophobic surfaces adsorb more plasma proteins
han those with hydrophilic character. This corresponds to the
owest platelet adhesion observed on the most hydrophilic sur-
ace of PANI–PAMPSA. Nevertheless, the differences in surface
ydrophilicity alone, measured on the tested surfaces, cannot
nambiguously explain the observed changes in either platelet
dhesion or blood coagulation.
able 4
ontact angle (◦) of individual surfaces.
PANI base PANI hydrochloride PANI–PAMPSA PANI-1:1
Water 63.33±2.47 44.97±3.53 34.21±1.46 69.95±3.422.5±0.5 0.4±0.0 1.0±0.0
ard deviation, n=3.
3.3. pH stability of PANI–PAMPSA ﬁlms
The UV–Vis spectra of the PANI–PAMPSA ﬁlms under different
pH were recorded with the aim to evaluate the pH of the transi-
tionbetween conductingPANI–PAMSAsalt and its non-conducting,
deprotonated base. From the spectra (Fig. 3) it is seen that, at
pH 2, PANI–PAMPSA has two absorption maxima typical for the
conducting PANI form, namely at 410nm and at approximately
840nm, which are assigned to the –* transition of the ben-
zenoid rings and the polaron band transitions, respectively [35].
The ﬁgure also illustrates that at pH higher than 5 the conversion
from the conducting salt to non-conducting base occurs. The evi-
dence of this transition is a gradual shift of the spectrum maxima
from 840nm towards lower values. At the same time the shift of
the maximum is not abrupt but gradual and, at pH>8, the max-
ima are located at 605–650nm, which corresponds to the n–*
transition of quinonoid rings. Under these conditions the ﬁlm is
fully deprotonated and non-conducting PANI base is formed. The
results obtained thus indicate that surface deposition of PANI with
PAMPSA improved the pH stability of the ﬁlm, which was able
to retain at least part of its conductivity at pH 6. In the compari-
son with standard PANI, emeraldine hydrochloride, with transition
fromsalt to base occurring at pH≈4 [36], this is clear improvement.
The enhanced stability under physiological conditions might be of
importance for PANI applications in biomedicine.
3.4. Spectroscopic investigation
The FTIR spectroscopic analysis has been performed (Fig. 4) to
prove the presence of PAMPSA in the ﬁlms and its interaction with
PANI. The infrared spectrumof PANI–PAMPSA strongly differs from
the spectrum of the original PANI base, and it is very close to the
spectrum of PANI hydrochloride, which exhibits the typical bandsFig. 3. UV–Vis spectra of the PANI–PAMPSA ﬁlms measured in buffer solutions
between pH 2 and 12.
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cig. 4. FTIR spectra of the in situ deposited standard PANI hydrochloride (S), PANI
ase (B), PANI–PAMPSA (D) and PANI-1:1(R) on silicon window in (a) high and (b)
ow wavenumber regions. Spectrum of neat PAMPSA is shown for comparison.
hey reﬂect the organization of PANI chains within the ﬁlm by
ydrogen bonding involving these groups. A relatively sharp peak
ith amaximumat 3225 cm−1 is attributed to the secondary amine
–H+ stretching vibrations hydrogen-bonded with hydrogen sul-
ateHSO4– and sulfate SO42– counter-ionswhich are present due to
he protonation of PANI with sulfuric acid which is a by-product of
he aniline oxidation (spectrumPANI-1:1). In the case of reprotona-
ion of PANI basewith PAMPSA this peak is stronger and it is shifted
o higher wavenumber 3250 cm−1 (spectrum PANI–PAMPSA). The
aximum of the broad band observed at 2990 cm−1 corresponds
o the stretching vibrations of –NH+ in protonated imine groups
onded by a hydrogen bond with hydrogen sulfate HSO4– or sul-
ate SO42– counter-ions. This supports the interaction of PANI with
AMPSA by stronger hydrogen bonding [12] and explains the fact
hat PANI–PAMPSAhas improvedpHstability in the transition from
onducting salt to non-conducting base.
The band typical of the conducting form of PANI is observed
t wavenumbers higher than 2000 cm−1 (Fig. 4b). Two main
ands with maxima situated at 1579 and 1492 cm−1, assigned to
uinonoid and benzenoid ring-stretching vibrations, respectively,
ominate the spectrum of protonated ﬁlm in the region bellow
000 cm−1. The absorption band corresponding to-electron delo-
alization induced in the polymer by protonation is situated atB: Biointerfaces 133 (2015) 278–285 283
1309 cm−1, the band of C∼N+• stretching vibrations is observed
at 1247 cm−1, and the prominent band situated at 1154 cm−1,
has been assigned to the vibrations of the –NH+ structure. The
region 900–700 cm−1 corresponds to the aromatic ring out-of-
plane deformation vibrations. The presence of PAMPSA on the
surface of PANI ﬁlm is reﬂected in the bands at 1654 and 1037 cm−1
observed also in the spectrum of PAMPSA (Fig. 4b).
The shift of the sharp peak present at 3225 cm−1 and the max-
imum of the broad band at 2990 cm–1 in the spectrum of PANI
salt is lower than in the case of the ﬁlm PANI–PAMPSA. This sig-
niﬁes that the hydrogen bonding of PAMPSA is weaker in the ﬁlm
of PANI-1:1. Thebroadpolaronbandabove2000 cm−1 disappeared,
as it is observed after deprotonation of the PANI salt to PANI base
(Fig. 4). The bands of quinonoid and benzenoid-ring vibrations shift
tohigherwavenumbers, 1593 cm−1 and1510 cm−1. Thebandof the
C–N stretching vibrations in the neighbourhood of a quinonoid ring
at 1378 cm−1 appeared in the spectrum of PANI-1:1 and of PANI
base. The 1309 cm−1 band of the C–N stretching of a secondary
aromatic amine and of the aromatic C–H in-plane bending modes
are observed in the region at about 1170 cm−1 and they are not
enhanced in the spectrum of PANI-1:1 and PANI base. Out-of-plane
deformations of C–H on 1,4-disubstituted rings are located in the
region of 800–880 cm−1. The presence of PAMPSA in the ﬁlm is also
reﬂectedby thebandspresent at 1654and1037 cm−1 observedalso
in the spectrum of PAMPSA (Fig. 4b).
3.5. General discussion
In blood-contacting devices, various polymers can be applied.
Just brieﬂy listed, catheters are made of poly(vinylchloride),
poly(tetraﬂuorethylene), polyethylene, polyurethanes and
polysiloxane; hemodialysis membranes of polyethersulfone and
regenerated cellulose, and oxygenator membranes of polysilox-
ane or polypropylene [39]. These polymers, however, do not
possess an electrical conductivity which can be important in some
applications where both conductivity and contact with blood are
expected, e.g. in vivo sensing materials.
Considering the complexity of material/blood interaction, some
general ruleshave tobeconsidered regardinghemocompatibilityof
the polymermaterials. It iswell known, that unchargedhydrophilic
surfaces exhibit low interaction with proteins and blood. Never-
theless, this is not a general rule, as for example plasma oxidation
of polyethylene substrate was reported to increase wettability
with increased protein adsorption while the platelet adhesion was
reduced [40]. With respect to hydrophilicity, hydrogels for applica-
tion in blood contacting deviceswere shown to be efﬁcient to cause
steric repulsion of blood proteins and were prepared for exam-
ple of poly(vinyl alcohol), poly(N-vinylpyrrolidone), poly(ethylene
oxide) or cellulose [41]. The poor mechanical properties of hydro-
gels can be avoided by their grafting on the surfaces of standard
polymers. However, highly hydrophobic polytetreaﬂuorethylene
or ﬂuorinated surfaces also show high hemocompatibility [42,43].
Surface chargeplaysalsoan important role. Positive surface charges
stimulateplatelet adhesionandactivation [44] andnegative surface
charges activate the plasmatic coagulation systems [29].
In general, there are several approaches to prepare modi-
ﬁed materials with improved hemocompatibility. The ﬁrst one,
passivation of the surface can be performed with the aim to
achieveminimal interactionwith blood proteins and cells. The next
approach relies in immobilization of active molecules interacting
with blood proteins and cells; and ﬁnally, promotion of the growth
of endothelial cells is also a possible way of modiﬁcation. In this
context, the surface ﬂuorination [45,46], immobilization of hep-
arin (e.g. [29]) as well PEGylation (immobilization of polyethylene
glycol) [47] can serve as examples of modiﬁed surfaces. Also, the
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revention of non-speciﬁc adsorption while selective adsorption
f proteins can lead to the desired bioactive function. In this con-
ext, themain advantages of PANI relies not only in its conductivity,
ut also in its ability to be modiﬁed by another biological active
ubstances or to act as a surface modiﬁer itself.
The mentioned protein adsorption can be also affected by
urface topography of a substrate. Rough surfaces adsorbmore pro-
eins than relatively smooth ones [48]. Moreover, the nanoscale
urface topography [49] can play an important role. As the polymer
hain of PAMPSA modiﬁes the surface topography of PANI, it can
lso contribute to a different anticoagulation activity on its surface.
. Conclusions
The PANI ﬁlm reprotonated with poly(2-acrylamido-2-methyl-
-propanesulfonic acid) had a signiﬁcant impact on blood
oagulation, which was hindered by the interaction with three
oagulation factors, Xa, Va and IIa. Such modiﬁed polymer ﬁlm
lso signiﬁcantly reduced platelet adhesion, when compared with
tandard PANI ﬁlms or uncoated reference surface, which exhib-
ted neither of the mentioned effects. Anticoagulation activity
nd reduction of platelet adhesion was attributed to pres-
nce of PAMPSA polyanion immobilized on PANI polycationic
urface. Reprotonation of PANI with poly(2-acrylamido-2-methyl-
-propanesulfonic acid) also yielded other interesting results,
amely improvedpH stability of the PANI–PAMPSApolymer.While
he standard PANI shows transition from non-conducting to con-
ucting form at pH below 4–6, PANI modiﬁed with PAMPSA
xhibited this transition at increased pH of 6. This is a notable
mprovement, shifting the conductivity of this polymer closer to
hysiological pH. The combination of conductivity, anticoagula-
ion activity, low platelet adhesion capacity as well as improved
H stability of PANI coated with poly(2-acrylamido-2-methyl-1-
ropanesulfonic acid) opens up new possibilities for application of
his polymer as a biomaterial, for example in blood-contacting or
ollecting devices or for in vivo sensing materials requiring men-
ioned properties.
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